| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.48 | 0.08 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |